Aegerion Pharmaceuticals, Inc. (AEGR): Sarissa Capital Management Files Amended 13D

Sarissa Capital Management filed an amended 13D today regarding Aegerion Pharmaceuticals (NASDAQ:AEGR) disclosing the confidentiality agreement between the activist hedge fund...

Keep Reading →